In a study of two groups of rats given a melanoma immunotherapy (programmed cell death-1 inhibitor) (PD-1 blocker), it was discovered that rats with gastrointestinal populations of Bifidobacterium longum had the same tumor control as those rats administered the anti-PD-1 therapy that was being studied. The gene discussed is PDCD1; the disease is melanoma.